|
⚲
|
| Keyboard |
| Alon Lazarus | |
|---|---|
| Firm | |
| Address | 1030 Massachusetts Ave, Suite 210 Cambridge, MA 02138 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Crossbow Therapeutics Inc | 021-559257 | Director | 30.2 M of 80.0 M |
||
| Auron Therapeutics Inc | 021-533785 | Director | 27.3 M of 42.3 M |
||
| Bluejay Therapeutics Inc | 021-512955 | Director | 182.0 M of 182.0 M |
||
| Entact Bio Inc | 021-503956 | Director | 40.3 M of 40.3 M |
||
| Reunion Neuroscience Inc | 021-503441 | Director | 119.8 M of 119.8 M |
||
| Bluejay Therapeutics Inc | 021-456062 | Director | 20.5 M of 41.2 M |
||
| Auron Therapeutics Inc | 021-454017 | Director | 38.4 M of 48.2 M |
||
| Werewolf Therapeutics Inc | 021-385514 | Director | 72.1 M of 72.1 M |
||
| Auron Therapeutics Inc | 021-383381 | Director | 15.4 M of 15.4 M |
||
| Keros Therapeutics Inc | 021-362700 | Director | 56.0 M of 56.0 M |
||
| Werewolf Therapeutics Inc | 021-346661 | Director | 56.2 M of 56.2 M |
||
| Keros Therapeutics Inc | 021-326320 | Director | 11.5 M of 23.0 M |
||
| Keros Therapeutics Inc | 021-262318 | Director | 11.0 M of 11.0 M |
||
| Oncorus Inc | 021-261269 | Director | 61.3 M of 61.4 M |
||